[go: up one dir, main page]

CA2189254A1 - Modulated release from biocompatible polymers - Google Patents

Modulated release from biocompatible polymers

Info

Publication number
CA2189254A1
CA2189254A1 CA002189254A CA2189254A CA2189254A1 CA 2189254 A1 CA2189254 A1 CA 2189254A1 CA 002189254 A CA002189254 A CA 002189254A CA 2189254 A CA2189254 A CA 2189254A CA 2189254 A1 CA2189254 A1 CA 2189254A1
Authority
CA
Canada
Prior art keywords
polymeric matrix
biologically active
active agent
metal cation
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002189254A
Other languages
French (fr)
Other versions
CA2189254C (en
Inventor
Howard Bernstein
Yan Zhang
M. Amin Khan
Mark A. Tracy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alkermes Controlled Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/237,057 external-priority patent/US5656297A/en
Application filed by Individual filed Critical Individual
Publication of CA2189254A1 publication Critical patent/CA2189254A1/en
Application granted granted Critical
Publication of CA2189254C publication Critical patent/CA2189254C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a composition for the modulated release of a biologically active agent. The composition comprises a biocompatible polymeric matrix, a biologically active agent which is dispersed within the polymeric matrix, and a metal cation component which is separately dispersed within the polymeric matrix, whereby the metal cation component modulates the release of the biologically active agent from the polymeric matrix. The present invention also relates to a method for modulating the release of a biologically active agent from a biocompatible polymeric matrix, comprising the steps of dissolving a biocompatible polymer in a solvent to form a polymer solution and also separately dispersing a metal cation component and a biologically active agent within the polymer solution. The polymer solution is then solidified to form a polymeric matrix, wherein at least a significant portion of the metal cation component is dispersed in the polymeric matrix separately from the biologically active protein, and whereby the metal cation component modulates the release of the biologically active agent from the polymeric matrix.
CA002189254A 1994-05-03 1995-05-03 Modulated release from biocompatible polymers Expired - Fee Related CA2189254C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/237,057 US5656297A (en) 1992-03-12 1994-05-03 Modulated release from biocompatible polymers
US08/237,057 1994-05-03
PCT/US1995/005511 WO1995029664A1 (en) 1994-05-03 1995-05-03 Modulated release from biocompatible polymers

Publications (2)

Publication Number Publication Date
CA2189254A1 true CA2189254A1 (en) 1995-11-09
CA2189254C CA2189254C (en) 2006-10-10

Family

ID=37111128

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002189254A Expired - Fee Related CA2189254C (en) 1994-05-03 1995-05-03 Modulated release from biocompatible polymers

Country Status (1)

Country Link
CA (1) CA2189254C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0810990D0 (en) 2008-06-16 2008-07-23 Q Chip Ltd Device and method of making solid beads

Also Published As

Publication number Publication date
CA2189254C (en) 2006-10-10

Similar Documents

Publication Publication Date Title
AU2467495A (en) Modulated release from biocompatible polymers
WO1996040073A3 (en) Composition for sustained release of non-aggregated erythropoietin
AU658715B2 (en) A process for the preparation of biologically active material-containing polymeric microcapsules
EP0967007A3 (en) Method for microencapsulating a solid substance
CA2304662A1 (en) Methods for fabricating polymer-based controlled release preparations
AU5106996A (en) Process for producing active agent preparations in the form of a solid solution of the active agent in a polymer matrix and active agent preparations obtained thereby
CA2228610A1 (en) Controlled release products
CA2214100A1 (en) Sustained release formulation containing three different types of polymers
CA2187353A1 (en) Liquid delivery compositions
AU5977300A (en) Microcapsules - ii
CA2219698A1 (en) Sustained-release preparation
BR9501319A (en) Topical cosmetic and / or dermatological composition use of this composition and cosmetic treatment process
WO2001001929A3 (en) Microcapsules iv
AU7756081A (en) Microencapsulation of water soluble polypeptides
HUT75247A (en) Solid pharmaceutical composition comprising an excipient capable of binding water and process for its production
AU5406600A (en) Microcapsules - i
CA2338605A1 (en) Pliable and moldable polymeric delivery system for bioactive agents
WO1999011298A3 (en) Reverse phase connective tissue repair composition
WO1998022097A3 (en) Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
EP0732105A3 (en) Affinity bound collagen matrices for the delivery of biologically active agents
CA2292586A1 (en) Solid pharmaceutical dosage forms in form of a particulate dispersion
CA2148342A1 (en) Encapsulation with water soluble polymer
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
CA2286900A1 (en) Methods for actively binding heparin to cross-linked biological tissues
SI0904063T1 (en) Process for the preparation of microparticles

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed